M
VRTX icon

Mirova’s Vertex Pharmaceuticals VRTX Stock Holding History

Mirova’s Portfolio VRTX Stock Details VRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.51M Sell
7,071
-3,312
-32% -$1.47M 0.13% 130
2026
Q1 		$4.64M Buy
+10,383
New +$4.84M 0.19% 122
2020
Q4 		– Sell
-99
Closed -$27K – 225
2020
Q3 		$27K Buy
99
+48
+94% +$13.2K ﹤0.01% 161
2020
Q2 		$15K Hold
51
– – ﹤0.01% 141
2020
Q1 		$12K Hold
51
– – ﹤0.01% 146
2019
Q4 		$11K Buy
+51
New +$10.3K ﹤0.01% 161

Other funds holding VRTX

Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Mirova's VRTX Position: Q2 2026 in Review

Mirova reduced its Vertex Pharmaceuticals (VRTX) stake by 32% in Q2 2026, selling an estimated $1.47M and leaving 7,071 shares worth $3.51M. The position accounts for 0.13% of the portfolio, ranked #130.

Mirova first reported a position in VRTX in Q4 2019 and has held it in 6 quarters since. The position peaked at $4.64M in Q1 2026. 1,747 funds tracked by Wall St. Rank hold VRTX as of Q2 2026.

  • Mirova held 7,071 shares of Vertex Pharmaceuticals worth $3.51M as of Q2 2026.
  • Mirova sold 3,312 Vertex Pharmaceuticals shares in Q2 2026, an estimated $1.47M.
  • Vertex Pharmaceuticals made up 0.13% of Mirova's portfolio in Q2 2026, its #130 holding.
  • Mirova first reported a position in Vertex Pharmaceuticals in Q4 2019 and has held it in 6 quarters since.
  • Mirova's Vertex Pharmaceuticals position peaked at $4.64M in Q1 2026.
  • 1,747 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q2 2026.

Based on Mirova's 13F filing for Q2 2026, filed 13 Aug 2026.